July 03, 2026 11:23 pm (IST)
Emerging markets affect Dr Reddy's Laboratories' December quarter performance
Hyderabad, Feb 9 (IBNS) Dr Reddy's Laboratories Ltd announced its consolidated financial results on Tuesday for the quarter ended December 31, 2015, where it posted consolidated revenue of ₹39.7 billion, up 3 per cent from the same period in 2014, largely because the healthy performance in North America Generics (NAG), Europe and India were partially offset by emerging markets, which were impacted by unfavorable macro-economic conditions.
Revenues from the Global Generics segment for the reported quarter was ₹33.6 billion, up 7 per cent from the year-ago quarter, primarily driven by North America, Europe and India.
Revenues from the Pharmaceutical Services and Active Ingredients (PSAI) segment was ₹5.1 billion in the reported quarter, and declined by 17 per cent from the same quarter a year ago.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Air India, SIA Engineering ink agreement for collaboration on MRO
Fri, Jul 03 2026
Government revives IDBI Bank privatisation; mega Rs 55,000 crore deal back on track
Thu, Jul 02 2026
India-US trade deal almost done! Piyush Goyal hints at breakthrough
Thu, Jul 02 2026
From rally to rout: Zee Entertainment shares crash after denying Rs 418 crore FDI report
Thu, Jul 02 2026
Renault India sustains growth momentum; June wholesales rise 55%
Wed, Jul 01 2026
Mahindra’s Trucks & Buses Business sells 3249 vehicles in June 2026
Wed, Jul 01 2026
Mahindra farm equipment business sells 58,177 Tractors in June 2026
Wed, Jul 01 2026
